Wedbush Maintains Outperform Rating and $58 PT on Unitedhealth Group
A report from Wedbush reiterates its Outperform rating and $58 price target on Unitedhealth Group (NYSE: UNH).
The report states, “Optum growth likely to drive 2012. We see potential for upside to current guidance of modest growth off of $4.40-4.45 in 2011 from: 1) growth in Optum, 2) continued low utilization and 3) MA enrollment upside.”
UNH closed yesterday at $45.34.







